Nu Skin Q2 revenue $439M, GAAP EPS $(2.38) on $141M impairment charge; guides FY24 revenue $1.73-1.81B

NU SKIN ENTERPRISES, INC.

2024-Q2 EPS reported -$2.39 revenue$856,387,000

Revenue $439.1M, down 12.2% YoY; FX headwind of 4.2% ($21.0M).
GAAP EPS $(2.38) vs $0.54 prior-year; adjusted EPS $0.21 excluding restructuring and impairment charges.
Recorded $141M non-cash goodwill and intangibles impairment charge due to stock price decline.
Rhyz segment revenue $67.8M (+32.3% YoY); core Nu Skin customers down 14% to 893,514.
Q3 2024 revenue guidance $430-$465M; FY2024 revenue narrowed to $1.73-$1.81B, adjusted EPS $0.75-$0.95.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.